KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Dividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Johnson & Johnson (JNJ) Capital Expenditures (2016 - 2025)

Historic Capital Expenditures for Johnson & Johnson (JNJ) over the last 17 years, with Q3 2025 value amounting to $1.2 billion.

  • Johnson & Johnson's Capital Expenditures rose 1243.93% to $1.2 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $4.6 billion, marking a year-over-year increase of 468.08%. This contributed to the annual value of $4.4 billion for FY2024, which is 261.94% down from last year.
  • According to the latest figures from Q3 2025, Johnson & Johnson's Capital Expenditures is $1.2 billion, which was up 1243.93% from $1.0 billion recorded in Q2 2025.
  • Over the past 5 years, Johnson & Johnson's Capital Expenditures peaked at $1.8 billion during Q1 2023, and registered a low of $607.0 million during Q2 2022.
  • Over the past 5 years, Johnson & Johnson's median Capital Expenditures value was $976.0 million (recorded in 2024), while the average stood at $1.1 billion.
  • In the last 5 years, Johnson & Johnson's Capital Expenditures soared by 4217.46% in 2023 and then plummeted by 1316.73% in 2024.
  • Over the past 5 years, Johnson & Johnson's Capital Expenditures (Quarter) stood at $747.0 million in 2021, then decreased by 18.74% to $607.0 million in 2022, then skyrocketed by 161.78% to $1.6 billion in 2023, then increased by 1.45% to $1.6 billion in 2024, then decreased by 28.23% to $1.2 billion in 2025.
  • Its Capital Expenditures stands at $1.2 billion for Q3 2025, versus $1.0 billion for Q2 2025 and $795.0 million for Q1 2025.